These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 36320345)

  • 21. Psychotic spectrum disorders and alcohol abuse: a review of pharmacotherapeutic strategies and a report on the effectiveness of naltrexone and disulfiram.
    Petrakis IL; Nich C; Ralevski E
    Schizophr Bull; 2006 Oct; 32(4):644-54. PubMed ID: 16887890
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Focus on: Neuroscience and treatment: the potential of neuroscience to inform treatment.
    Koob GF
    Alcohol Res Health; 2010; 33(1-2):144-51. PubMed ID: 23579944
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gender differences in alcohol treatment: an analysis of outcome from the COMBINE study.
    Greenfield SF; Pettinati HM; O'Malley S; Randall PK; Randall CL
    Alcohol Clin Exp Res; 2010 Oct; 34(10):1803-12. PubMed ID: 20645934
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacological treatment of alcohol dependence: a review of the evidence.
    Garbutt JC; West SL; Carey TS; Lohr KN; Crews FT
    JAMA; 1999 Apr; 281(14):1318-25. PubMed ID: 10208148
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment implications: using neuroscience to guide the development of new pharmacotherapies for alcoholism.
    Krishnan-Sarin S; O'Malley S; Krystal JH
    Alcohol Res Health; 2008; 31(4):400-7. PubMed ID: 23584013
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy of naltrexone and acamprosate for alcoholism treatment: a meta-analysis.
    Kranzler HR; Van Kirk J
    Alcohol Clin Exp Res; 2001 Sep; 25(9):1335-41. PubMed ID: 11584154
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diagnosis and Pharmacotherapy of Alcohol Use Disorder: A Review.
    Kranzler HR; Soyka M
    JAMA; 2018 Aug; 320(8):815-824. PubMed ID: 30167705
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identifying adolescents with alcohol use disorder: Optimal screening using the National Institute on Alcohol Abuse and Alcoholism screening guide.
    Parast L; Meredith LS; Stein BD; Shadel WG; D'Amico EJ
    Psychol Addict Behav; 2018 Aug; 32(5):508-516. PubMed ID: 29975071
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacotherapy of alcohol use disorders in the Veterans Health Administration.
    Harris AH; Kivlahan DR; Bowe T; Humphreys KN
    Psychiatr Serv; 2010 Apr; 61(4):392-8. PubMed ID: 20360279
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Physicians' opinions about medications to treat alcoholism.
    Mark TL; Kranzler HR; Song X; Bransberger P; Poole VH; Crosse S
    Addiction; 2003 May; 98(5):617-26. PubMed ID: 12751979
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Challenges and opportunities for medications development in alcoholism: an international perspective on collaborations between academia and industry.
    Johnson BA; Mann K; Willenbring ML; Litten RZ; Swift RM; Lesch OM; Berglund M
    Alcohol Clin Exp Res; 2005 Aug; 29(8):1528-40. PubMed ID: 16156050
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Study characteristics influence the efficacy of substance abuse treatments: A meta-analysis of medications for alcohol use disorder.
    Klemperer EM; Hughes JR; Naud S
    Drug Alcohol Depend; 2018 Sep; 190():229-234. PubMed ID: 30059816
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Alcohol use disorders and current pharmacological therapies: the role of GABA(A) receptors.
    Liang J; Olsen RW
    Acta Pharmacol Sin; 2014 Aug; 35(8):981-93. PubMed ID: 25066321
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Research opportunities for medications to treat alcohol dependence: addressing stakeholders' needs.
    Litten RZ; Falk D; Ryan M; Fertig J
    Alcohol Clin Exp Res; 2014 Jan; 38(1):27-32. PubMed ID: 23889161
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Defining Recovery From Alcohol Use Disorder: Development of an NIAAA Research Definition.
    Hagman BT; Falk D; Litten R; Koob GF
    Am J Psychiatry; 2022 Nov; 179(11):807-813. PubMed ID: 35410494
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relationship of negative emotionality, NIAAA recovery, and 3- and 6-month drinking outcomes among adults in treatment for alcohol use disorder.
    Linn BK; Zhao J; Stasiewicz PR; LaBarre C; Wilding GE; Bradizza CM
    Drug Alcohol Depend; 2023 Jan; 242():109695. PubMed ID: 36442440
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Medication Development for Alcohol Use Disorder: A Focus on Clinical Studies.
    Leggio L; Falk DE; Ryan ML; Fertig J; Litten RZ
    Handb Exp Pharmacol; 2020; 258():443-462. PubMed ID: 31628604
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Alcohol research: past, present, and future.
    Gunzerath L; Hewitt BG; Li TK; Warren KR
    Ann N Y Acad Sci; 2011 Jan; 1216():1-23. PubMed ID: 21182533
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Medications for treating alcohol dependence.
    Williams SH
    Am Fam Physician; 2005 Nov; 72(9):1775-80. PubMed ID: 16300039
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A longitudinal examination of alcohol pharmacotherapy adoption in substance use disorder treatment programs: patterns of sustainability and discontinuation.
    Abraham AJ; Knudsen HK; Roman PM
    J Stud Alcohol Drugs; 2011 Jul; 72(4):669-77. PubMed ID: 21683049
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.